John Tilton
Overview
John Tilton received $2M in total compensation, including $309K in salary, at Biohaven Pharmaceutical Holding Co Ltd. in 2018.
Source: SEC filing on April 11, 2019.
Related executives
We found six more executives who work or worked at Biohaven Pharmaceutical Holding Co Ltd..
Vlad Coric
Biohaven Pharmaceutical Holding Co Ltd.
Chief Executive Officer
William Jones
Biohaven Pharmaceutical Holding Co Ltd.
Chief Commercial Officer of Migraine & Common Diseases
Kimberly Gentile
Biohaven Pharmaceutical Holding Co Ltd.
Senior Vice President, Clinical Operations
James Engelhart
Biohaven Pharmaceutical Holding Co Ltd.
Chief Financial Officer
Elyse Stock
Biohaven Pharmaceutical Holding Co Ltd.
Chief Medical Officer
Charles Conway
Biohaven Pharmaceutical Holding Co Ltd.